In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
This content is intended for U.S. Healthcare Professionals. Would you like to proceed?
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
M.V.I. Adult™ is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and pediatric patients aged 11 years and above receiving parenteral nutrition.
M.V.I. Adult is a combination product that contains the following vitamins: ascorbic...
M.V.I. Adult is an injection available as a:
M.V.I. Adult is contraindicated in patients who have:
M.V.I. Adult contains Vitamin K which may decrease the anticoagulant effect of warfarin. In...
The following adverse reactions are discussed in greater detail in other section of the labeling.
Phenytoin: Folic acid may increase phenytoin metabolism and lower the...
Administration of the...
Signs and symptoms of acute or chronic overdosage may be those of individual M.V.I. Adult component toxicity. There is no clinical experience with M.V.I. Adult overdosage.
M.V.I. Adult (multiple vitamins injection) is a sterile product consisting of two vials provided as a single dose or as a pharmacy bulk package for intravenous use intended for administration by intravenous...
Carcinogenicity, mutagenicity and fertility studies were not performed.
M.V.I. ADULT is an injection supplied in the following package configurations:
M.V.I. ADULT Single-Dose
Instruct patients (if age appropriate) and caregivers:
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at https://vaers.hhs.gov or call (800) 822-7967.